News & Stories

Exhibition for HKSAR 25th and HKUST 30th Anniversaries

Under the MoU, both parties will nurture local talent in knowledge relating to data analytics, cloud computing and AI.

HKUST is committed to building MetaHKUST – an extended reality (XR) campus for both HKUST and its Guangzhou counterpart set to be open in September.

A tech company to shore up the country’s semiconductor capabilities and performance standards.

A research team at The Hong Kong University of Science and Technology (HKUST) has developed a new electrode design that is set to enable the rechargeability of alkaline zinc batteries, one of the most common types of non-rechargeable batteries used in our daily lives, shedding light on a wider application of rechargeable batteries. Batteries are ever important in the age of smart cities and global digitalization. Yet, a majority of batteries in the market are not rechargeable, or called primary batteries. They are disposed after a single use, an unsustainable practice that poses a serious threat to the environment.

The National Winter Olympic Team shares their inspiring stories in a live sharing session at HKUST.

Structural biologists at The Hong Kong University of Science and Technology (HKUST) together with researchers at the AIDS Institute, The University of Hong Kong (HKU), Department of Microbiology, School of Clinical Medicine, the LKS Faculty of Medicine of The University of Hong Kong (HKUMed) and the State Key Laboratory of Emerging Infectious Diseases, HKU have demonstrated that ZCB11, a broadly neutralising antibody derived from a local mRNA-vaccinee against the spreading Omicron variants of SARS-CoV-2, displays potent antiviral activities against all variants of concern (VOCs), including the dominantly spreading Omicron BA.1, BA1.1 and BA.2. Critically, either prophylactic or therapeutic ZCB11 administration protects lung infection against Omicron viral challenge in golden Syrian hamsters.

HKUST will enhance its flexible admissions arrangement for students applying for 2022 intake via JUPAS.